Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

antineoplaston AS2-1

A 4:1 mixture of phenylacetate and phenylacetylgluatmine, degradation products of the antineoplaston agent A10. Antineoplaston AS2-1 inhibits the incorporation of L-glutamine into tumor-cell proteins, leading to cell cycle arrest in the G1 phase and inhibition of mitosis. This agent may also inhibit RAS oncogene expression and activate tumor suppressor gene p53, resulting in cell differentiation and apoptosis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Astugenal
Abbreviation:AS2-1
Chemical structure:L-glutamine, N2-(phenylacetyl)-, monosodium salt, mixture with sodium benzeneacetate
IND number:43013
NSC code:620261
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search